Rexahn Pharmaceuticals Inc is categorized under Noncommercial Biotechnical Research in Rockville, MD and active since 2005.
Rexahn Pharmaceuticals Inc was established in 2005, and today employs 1 to 4, earning Unknown per year. This is a Noncommercial Biotechnical Research business, which does work in the B2B market, and is classified as a Noncommercial Biotechnical Research, under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Peter Suzdak, Chief Executive Officer at the company’s headquarters by writing to 15245 Shady Grove Road # 455, Rockville, Maryland MD 20850 or by phoning (240) 268-5300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Rexahn Pharmaceuticals Inc |
Contact Person: | Peter Suzdak, Chief Executive Officer |
Address: | 15245 Shady Grove Road # 455, Rockville, Maryland 20850 |
Phone Number: | (240) 268-5300 |
Website Address: | rexahn.com |
Annual Revenue (USD): | Unknown |
Founded: | 2005 |
Location Type: | Headquarters |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Noncommercial Biotechnical Research |
SIC Code: | 8733 |
NAICS Code: | 3254120 |
Share This Business: |
Rexahn Pharmaceuticals Inc was started in 2005 to provide professional Noncommercial Biotechnical Research under the SIC code 8733 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Peter Suzdak, Chief Executive Officer for inquiries that concern Rexahn Pharmaceuticals Inc by calling the company number (240) 268-5300, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Rexahn Pharmaceuticals Inc can be found at the coordinates 39.10783,-77.18908 as well as the street address 15245 Shady Grove Road # 455 in Rockville, Maryland 20850.
For its online presence, you may visit Rexahn Pharmaceuticals Inc’s website at rexahn.com and engage with its social media outlets through on Twitter and on Facebook.